血栓通联合低分子肝素钙治疗进展性缺血性脑卒中临床观察

Clinical observation of Xueshuantong combined with low molecular heparin calciumin treating progressive ischemic stroke

关键词:  血栓通  低分子肝素钙  联合治疗  进展性脑卒中  分析研究

Key words:  Xueshuantong  low molecular weight heparin calcium  combined therapy  progressive stroke  analysis and research

摘要:

[目的] 全面分析血栓通联合低分子肝素钙方式在进展性缺血性脑卒中治疗的具体应用及临床价值。[方法] 选择120例进展性脑卒中患者作为本次观察对象，随机分为实验组与对照组，每组60例，两组患者均接受常规治疗，并每天注射1次生理盐水与0.3 g血栓通液体混合溶液，晚上口服0.1 g肠溶阿司匹林，实验组在此基础上每天注射两次低分子肝素。[结果] 对照组治愈14例，显效15例，有效19例，无效12例，总有效率为80.00%；实验组治愈21例，显效27例，有效8例，无效4例，总有效率为93.33%；两组总有效率比较差异存在统计学意义（P<0.05）。[结论] 血栓通联合低分子肝素钙用于治疗进展性脑卒中具有较好的疗效。

Abstract:

[Objective] To analyze the specific application and the clinical value of Xueshuantong combined with low molecular heparin calcium in the treatment of progressive ischemic stroke. [Methods] The 120 patients with progressive stroke were served as the observation objects. They were randomly divided into control group and experimental group, receiving routine treatment first, and then injected with 0.9%NS and 0.3 g Xueshuantong liquid mixture once a day, oral 0.1g enteric coated aspirin at night. On the basis of the above treatment, in the experimental group a low molecular weight heparin was injected twice a day. [Results] In the control group, 12 cases were invalid, 19 cases effective, 15 cases excellent,14 cases cured and the total effective rate was 80%; in the experimental group, 4 cases were invalid, 8 cases effective, 27 cases excellent, 21 cases cured and the total effective rate was 93.33%. There was a statistical significant difference in the total effective rate between two groups (P<0.05). [Conclusion] Xueshuantong combined with low molecular weight heparin calcium has good clinical effect.